{
"info": {
"nct_id": "NCT04984980",
"official_title": "Efficacy and Safety of the Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Initially Unresectable Biliary Tract Cancer",
"inclusion_criteria": "1. Age ≥18 and ≤80 years;\n2. ECOG 0~1;\n3. Histologically or cytologically confirmed carcinoma of the bile duct or gallbladder;\n4. Imaging assessment of disease stage III/IVA/any TN1M0*;\n5. The main organs have good functions and the examination indexes meet the following requirements:\n6. Blood routine test:\n\n Hemoglobin ≥90 g/L (no blood transfusion within 14 days); Neutrophils count ≥1.5×10^9/L; Platelet count ≥80×10^9/L;\n7. Biochemical tests:\n\n Total bilirubin ≤2×ULN (upper limit of normal value); Blood alanine aminotransferase (ALT) or blood aspartate aminotransferase (AST) ≤ 2.5×ULN; Endogenous creatinine clearance rate ≥ 50 mL /min (Cockcroft-Gault formula);\n8. Voluntarily signed the informed consent;\n9. Good compliance and family members are willing to cooperate with follow-up.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
"exclusion_criteria": "1. Other uncured malignancies;\n2. Pregnant or lactating women, if the subject becomes pregnant during the study period, should withdraw from the clinical trial;\n3. Previous anti-tumor therapy for the disease in this study;\n4. Participated in other drug clinical trials within one month;\n5. Patients with known history of other systemic serious diseases before screening;\n6. Long-term unhealed wounds or incomplete healed fractures;\n7. Have a history of organ transplantation;\n8. Abnormal blood coagulation, with bleeding tendency (14 days before randomization must meet: INR within the normal range without the use of anticoagulants); Patients treated with anticoagulants or vitamin K antagonists such as warfarin, heparin or their analogs; The use of low-dose warfarin (1 mg orally, once daily) or low-dose aspirin (not more than 100 mg daily) for prophylactic purposes is permitted, provided that INR is less than 1.5;\n9. The incidence of arterial/venous thrombosis events in the previous year, such as cerebrovascular accident (including temporary ischemic attack), deep venous thrombosis and pulmonary embolism, was screened;\n10. People with a history of psychotropic substance abuse and unable to get rid of it or with mental disorders; Have a history of immunodeficiency, or other acquired or congenital immunodeficiency diseases, or have a history of organ transplantation;\n\n12. Concomitant diseases that, in the Investigator's judgment, seriously endanger patient safety or affect patient completion of the study.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "1. Age ≥18 and ≤80 years;",
"criterions": [
{
"exact_snippets": "Age ≥18 and ≤80 years",
"criterion": "age",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 80,
"unit": "years"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Age ≥18 and ≤80 years",
"criterion": "age",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 80,
"unit": "years"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "2. ECOG 0~1;",
"criterions": [
{
"exact_snippets": "ECOG 0~1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "ECOG 0~1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
}
]
}
},
{
"identified_line": {
"line": "3. Histologically or cytologically confirmed carcinoma of the bile duct or gallbladder;",
"criterions": [
{
"exact_snippets": "Histologically or cytologically confirmed carcinoma of the bile duct",
"criterion": "carcinoma of the bile duct",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
},
{
"exact_snippets": "Histologically or cytologically confirmed carcinoma of the ... gallbladder",
"criterion": "carcinoma of the gallbladder",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Histologically or cytologically confirmed carcinoma of the bile duct",
"criterion": "carcinoma of the bile duct",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
},
{
"exact_snippets": "Histologically or cytologically confirmed carcinoma of the ... gallbladder",
"criterion": "carcinoma of the gallbladder",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
}
]
}
},
{
"identified_line": {
"line": "4. Imaging assessment of disease stage III/IVA/any TN1M0*;",
"criterions": [
{
"exact_snippets": "Imaging assessment of disease stage III/IVA/any TN1M0",
"criterion": "disease stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"III",
"IVA",
"any TN1M0"
]
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Imaging assessment of disease stage III/IVA/any TN1M0",
"criterion": "disease stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"III",
"IVA",
"any TN1M0"
]
}
}
]
}
},
{
"identified_line": {
"line": "5. The main organs have good functions and the examination indexes meet the following requirements:",
"criterions": [
{
"exact_snippets": "The main organs have good functions",
"criterion": "main organ functions",
"requirement": {
"requirement_type": "functionality",
"expected_value": "good"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "The main organs have good functions",
"criterion": "main organ functions",
"requirement": {
"requirement_type": "functionality",
"expected_value": "good"
}
}
]
}
},
{
"identified_line": {
"line": "6. Blood routine test:",
"criterions": [
{
"exact_snippets": "Blood routine test",
"criterion": "blood routine test",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Blood routine test",
"criterion": "blood routine test",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Hemoglobin ≥90 g/L (no blood transfusion within 14 days); Neutrophils count ≥1.5×10^9/L; Platelet count ≥80×10^9/L;",
"criterions": [
{
"exact_snippets": "Hemoglobin ≥90 g/L (no blood transfusion within 14 days)",
"criterion": "hemoglobin level",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 90,
"unit": "g/L"
}
}
},
{
"exact_snippets": "Hemoglobin ≥90 g/L (no blood transfusion within 14 days)",
"criterion": "hemoglobin level",
"requirement": {
"requirement_type": "blood transfusion",
"expected_value": false
}
},
{
"exact_snippets": "Neutrophils count ≥1.5×10^9/L",
"criterion": "neutrophils count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1.5,
"unit": "×10^9/L"
}
}
},
{
"exact_snippets": "Platelet count ≥80×10^9/L",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 80,
"unit": "×10^9/L"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Hemoglobin ≥90 g/L (no blood transfusion within 14 days)",
"criterion": "hemoglobin level",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 90,
"unit": "g/L"
}
}
},
{
"exact_snippets": "Hemoglobin ≥90 g/L (no blood transfusion within 14 days)",
"criterion": "hemoglobin level",
"requirement": {
"requirement_type": "blood transfusion",
"expected_value": false
}
}
]
},
{
"exact_snippets": "Neutrophils count ≥1.5×10^9/L",
"criterion": "neutrophils count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1.5,
"unit": "×10^9/L"
}
}
},
{
"exact_snippets": "Platelet count ≥80×10^9/L",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 80,
"unit": "×10^9/L"
}
}
}
]
}
},
{
"identified_line": {
"line": "7. Biochemical tests:",
"criterions": [
{
"exact_snippets": "Biochemical tests",
"criterion": "biochemical tests",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Biochemical tests",
"criterion": "biochemical tests",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Total bilirubin ≤2×ULN (upper limit of normal value); Blood alanine aminotransferase (ALT) or blood aspartate aminotransferase (AST) ≤ 2.5×ULN; Endogenous creatinine clearance rate ≥ 50 mL /min (Cockcroft-Gault formula);",
"criterions": [
{
"exact_snippets": "Total bilirubin ≤2×ULN",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "×ULN"
}
}
},
{
"exact_snippets": "Blood alanine aminotransferase (ALT) ... ≤ 2.5×ULN",
"criterion": "blood alanine aminotransferase (ALT)",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "×ULN"
}
}
},
{
"exact_snippets": "blood aspartate aminotransferase (AST) ≤ 2.5×ULN",
"criterion": "blood aspartate aminotransferase (AST)",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "×ULN"
}
}
},
{
"exact_snippets": "Endogenous creatinine clearance rate ≥ 50 mL /min (Cockcroft-Gault formula)",
"criterion": "endogenous creatinine clearance rate",
"requirement": {
"requirement_type": "rate",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "mL/min"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Total bilirubin ≤2×ULN",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "×ULN"
}
}
},
{
"and_criteria": [
{
"exact_snippets": "Blood alanine aminotransferase (ALT) ... ≤ 2.5×ULN",
"criterion": "blood alanine aminotransferase (ALT)",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "×ULN"
}
}
},
{
"exact_snippets": "blood aspartate aminotransferase (AST) ≤ 2.5×ULN",
"criterion": "blood aspartate aminotransferase (AST)",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "×ULN"
}
}
}
]
},
{
"exact_snippets": "Endogenous creatinine clearance rate ≥ 50 mL /min (Cockcroft-Gault formula)",
"criterion": "endogenous creatinine clearance rate",
"requirement": {
"requirement_type": "rate",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "mL/min"
}
}
}
]
}
},
{
"identified_line": {
"line": "8. Voluntarily signed the informed consent;",
"criterions": [
{
"exact_snippets": "Voluntarily signed the informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "signed",
"expected_value": true
}
},
{
"exact_snippets": "Voluntarily signed the informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "voluntary",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Voluntarily signed the informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "signed",
"expected_value": true
}
},
{
"exact_snippets": "Voluntarily signed the informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "voluntary",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "9. Good compliance and family members are willing to cooperate with follow-up.",
"criterions": [
{
"exact_snippets": "Good compliance",
"criterion": "compliance",
"requirement": {
"requirement_type": "quality",
"expected_value": "good"
}
},
{
"exact_snippets": "family members are willing to cooperate with follow-up",
"criterion": "family members' cooperation",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Good compliance",
"criterion": "compliance",
"requirement": {
"requirement_type": "quality",
"expected_value": "good"
}
},
{
"exact_snippets": "family members are willing to cooperate with follow-up",
"criterion": "family members' cooperation",
"requirement": {
"requirement_type": "willingness",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 80 Years",
"criterions": [
{
"exact_snippets": "maximum age of 80 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 80,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 80 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 80,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "1. Other uncured malignancies;",
"criterions": [
{
"exact_snippets": "Other uncured malignancies",
"criterion": "uncured malignancies",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Other uncured malignancies",
"criterion": "uncured malignancies",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "3. Previous anti-tumor therapy for the disease in this study;",
"criterions": [
{
"exact_snippets": "Previous anti-tumor therapy for the disease",
"criterion": "previous anti-tumor therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Previous anti-tumor therapy for the disease",
"criterion": "previous anti-tumor therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "4. Participated in other drug clinical trials within one month;",
"criterions": [
{
"exact_snippets": "Participated in other drug clinical trials within one month",
"criterion": "participation in other drug clinical trials",
"requirement": {
"requirement_type": "time since last participation",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "month"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Participated in other drug clinical trials within one month",
"criterion": "participation in other drug clinical trials",
"requirement": {
"requirement_type": "time since last participation",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "month"
}
}
}
]
}
},
{
"identified_line": {
"line": "5. Patients with known history of other systemic serious diseases before screening;",
"criterions": [
{
"exact_snippets": "known history of other systemic serious diseases",
"criterion": "systemic serious diseases",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "known history of other systemic serious diseases",
"criterion": "systemic serious diseases",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "6. Long-term unhealed wounds or incomplete healed fractures;",
"criterions": [
{
"exact_snippets": "Long-term unhealed wounds",
"criterion": "wounds",
"requirement": {
"requirement_type": "healing status",
"expected_value": "unhealed"
}
},
{
"exact_snippets": "Long-term unhealed wounds",
"criterion": "wounds",
"requirement": {
"requirement_type": "duration",
"expected_value": "long-term"
}
},
{
"exact_snippets": "incomplete healed fractures",
"criterion": "fractures",
"requirement": {
"requirement_type": "healing status",
"expected_value": "incomplete"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Long-term unhealed wounds",
"criterion": "wounds",
"requirement": {
"requirement_type": "healing status",
"expected_value": "unhealed"
}
},
{
"exact_snippets": "Long-term unhealed wounds",
"criterion": "wounds",
"requirement": {
"requirement_type": "duration",
"expected_value": "long-term"
}
}
]
},
{
"exact_snippets": "incomplete healed fractures",
"criterion": "fractures",
"requirement": {
"requirement_type": "healing status",
"expected_value": "incomplete"
}
}
]
}
},
{
"identified_line": {
"line": "7. Have a history of organ transplantation;",
"criterions": [
{
"exact_snippets": "history of organ transplantation",
"criterion": "organ transplantation",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "history of organ transplantation",
"criterion": "organ transplantation",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "8. Abnormal blood coagulation, with bleeding tendency (14 days before randomization must meet: INR within the normal range without the use of anticoagulants); Patients treated with anticoagulants or vitamin K antagonists such as warfarin, heparin or their analogs; The use of low-dose warfarin (1 mg orally, once daily) or low-dose aspirin (not more than 100 mg daily) for prophylactic purposes is permitted, provided that INR is less than 1.5;",
"criterions": [
{
"exact_snippets": "Abnormal blood coagulation, with bleeding tendency",
"criterion": "blood coagulation",
"requirement": {
"requirement_type": "abnormality",
"expected_value": true
}
},
{
"exact_snippets": "Abnormal blood coagulation, with bleeding tendency",
"criterion": "blood coagulation",
"requirement": {
"requirement_type": "bleeding tendency",
"expected_value": true
}
},
{
"exact_snippets": "INR within the normal range without the use of anticoagulants",
"criterion": "INR",
"requirement": {
"requirement_type": "range",
"expected_value": "within the normal range"
}
},
{
"exact_snippets": "INR within the normal range without the use of anticoagulants",
"criterion": "INR",
"requirement": {
"requirement_type": "anticoagulant use",
"expected_value": false
}
},
{
"exact_snippets": "Patients treated with anticoagulants or vitamin K antagonists such as warfarin, heparin or their analogs",
"criterion": "anticoagulant or vitamin K antagonist treatment",
"requirement": {
"requirement_type": "treatment",
"expected_value": true
}
},
{
"exact_snippets": "The use of low-dose warfarin (1 mg orally, once daily) or low-dose aspirin (not more than 100 mg daily) for prophylactic purposes is permitted, provided that INR is less than 1.5",
"criterion": "low-dose warfarin or aspirin use",
"requirement": {
"requirement_type": "prophylactic use",
"expected_value": true
}
},
{
"exact_snippets": "The use of low-dose warfarin (1 mg orally, once daily) or low-dose aspirin (not more than 100 mg daily) for prophylactic purposes is permitted, provided that INR is less than 1.5",
"criterion": "low-dose warfarin or aspirin use",
"requirement": {
"requirement_type": "INR",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "N/A"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Abnormal blood coagulation, with bleeding tendency",
"criterion": "blood coagulation",
"requirement": {
"requirement_type": "abnormality",
"expected_value": true
}
},
{
"exact_snippets": "Abnormal blood coagulation, with bleeding tendency",
"criterion": "blood coagulation",
"requirement": {
"requirement_type": "bleeding tendency",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "INR within the normal range without the use of anticoagulants",
"criterion": "INR",
"requirement": {
"requirement_type": "range",
"expected_value": "within the normal range"
}
},
{
"exact_snippets": "INR within the normal range without the use of anticoagulants",
"criterion": "INR",
"requirement": {
"requirement_type": "anticoagulant use",
"expected_value": false
}
}
]
}
]
},
{
"exact_snippets": "Patients treated with anticoagulants or vitamin K antagonists such as warfarin, heparin or their analogs",
"criterion": "anticoagulant or vitamin K antagonist treatment",
"requirement": {
"requirement_type": "treatment",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "The use of low-dose warfarin (1 mg orally, once daily) or low-dose aspirin (not more than 100 mg daily) for prophylactic purposes is permitted, provided that INR is less than 1.5",
"criterion": "low-dose warfarin or aspirin use",
"requirement": {
"requirement_type": "prophylactic use",
"expected_value": true
}
},
{
"exact_snippets": "The use of low-dose warfarin (1 mg orally, once daily) or low-dose aspirin (not more than 100 mg daily) for prophylactic purposes is permitted, provided that INR is less than 1.5",
"criterion": "low-dose warfarin or aspirin use",
"requirement": {
"requirement_type": "INR",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "N/A"
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "9. The incidence of arterial/venous thrombosis events in the previous year, such as cerebrovascular accident (including temporary ischemic attack), deep venous thrombosis and pulmonary embolism, was screened;",
"criterions": [
{
"exact_snippets": "incidence of arterial/venous thrombosis events in the previous year",
"criterion": "arterial/venous thrombosis events",
"requirement": {
"requirement_type": "incidence",
"expected_value": "in the previous year"
}
},
{
"exact_snippets": "cerebrovascular accident (including temporary ischemic attack)",
"criterion": "cerebrovascular accident",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "deep venous thrombosis",
"criterion": "deep venous thrombosis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "pulmonary embolism",
"criterion": "pulmonary embolism",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "incidence of arterial/venous thrombosis events in the previous year",
"criterion": "arterial/venous thrombosis events",
"requirement": {
"requirement_type": "incidence",
"expected_value": "in the previous year"
}
},
{
"exact_snippets": "cerebrovascular accident (including temporary ischemic attack)",
"criterion": "cerebrovascular accident",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "incidence of arterial/venous thrombosis events in the previous year",
"criterion": "arterial/venous thrombosis events",
"requirement": {
"requirement_type": "incidence",
"expected_value": "in the previous year"
}
},
{
"exact_snippets": "deep venous thrombosis",
"criterion": "deep venous thrombosis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "incidence of arterial/venous thrombosis events in the previous year",
"criterion": "arterial/venous thrombosis events",
"requirement": {
"requirement_type": "incidence",
"expected_value": "in the previous year"
}
},
{
"exact_snippets": "pulmonary embolism",
"criterion": "pulmonary embolism",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"identified_line": {
"line": "2. Pregnant or lactating women, if the subject becomes pregnant during the study period, should withdraw from the clinical trial;",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "lactating women",
"criterion": "lactation",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "if the subject becomes pregnant during the study period",
"criterion": "pregnancy during study",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "lactating women",
"criterion": "lactation",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "10. People with a history of psychotropic substance abuse and unable to get rid of it or with mental disorders; Have a history of immunodeficiency, or other acquired or congenital immunodeficiency diseases, or have a history of organ transplantation;",
"criterions": [
{
"exact_snippets": "history of psychotropic substance abuse",
"criterion": "psychotropic substance abuse",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "unable to get rid of it",
"criterion": "psychotropic substance abuse",
"requirement": {
"requirement_type": "current status",
"expected_value": "unable to quit"
}
},
{
"exact_snippets": "mental disorders",
"criterion": "mental disorders",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "history of immunodeficiency",
"criterion": "immunodeficiency",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "acquired or congenital immunodeficiency diseases",
"criterion": "immunodeficiency diseases",
"requirement": {
"requirement_type": "type",
"expected_value": [
"acquired",
"congenital"
]
}
},
{
"exact_snippets": "history of organ transplantation",
"criterion": "organ transplantation",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "12. Concomitant diseases that, in the Investigator's judgment, seriously endanger patient safety or affect patient completion of the study.",
"criterions": [
{
"exact_snippets": "Concomitant diseases ... seriously endanger patient safety",
"criterion": "concomitant diseases",
"requirement": {
"requirement_type": "impact on patient safety",
"expected_value": "seriously endanger"
}
},
{
"exact_snippets": "Concomitant diseases ... affect patient completion of the study",
"criterion": "concomitant diseases",
"requirement": {
"requirement_type": "impact on study completion",
"expected_value": "affect"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_miscellaneous": []
}